Webinar recap: A Transformation of Pandemic Proportions for Clinical Teams
Experts share how their engagement strategies will continue to evolve.
The virtual future of in-person medical congresses
How will life science companies approach medical congresses post-pandemic? Read on to learn 3 benefits of adding virtual elements to in-person meetings.
What’s the difference between virtual meetings and virtual work?
The downside of endless video calls is more than just fatigue – your timelines and objectives might be suffering, too.
How to get more from virtual engagements in life science
Industry experts share the benefits of a hybrid virtual strategy.
Are you prepared for a hybrid future?
Here’s what you need – and why – to build a better virtual engagement strategy.
How to use big data analytics for clinical trials
The advantages and drawbacks of big data in clinical studies.
Event recap: Fierce Medical Affairs Strategic Summit
Hybrid engagements are the gold standard for medical affairs KOL engagement. Why? Diversity, cross-functional connectivity, and more comprehensive feedback.
Top 4 benefits of hybrid virtual engagement
If you don’t have a hybrid strategy, here’s what you might be missing.
How to improve demographic data in clinical trials
More diversity in clinical trial patient populations results in better treatments for everyone. Here are some ways life science companies are tackling the problem.
What is the value of transformation?
Going 100% virtual changed everything about how life science companies gather insights to fuel their critical work.